期刊文献+

前列腺干细胞抗原与相关癌症的研究进展 被引量:1

Prostate Stem Cell Antigen and Related Cancers
下载PDF
导出
摘要 前列腺干细胞抗原 (PSCA)为一种细胞表面抗原 ,在正常前列腺中表达 ,在前列腺癌、膀胱癌及胰腺癌组织中过度表达。PSCA在前列腺癌监测中敏感性优于PSA。PSCA可用于制备蛋白疫苗和基因疫苗 ,为癌症诊断与治疗提供新的方向与思路 ;进一步研究可以明确其有效性与安全性。 Prostate stem cell antigen (PSCA) is a cell surface antigen expressed in normal prostate and overexpressed in cancers associated with prostate, bladder and pancreas. The sensitivity of PSCA labeling is higher than PSA in prostate cancer. PSCA can be used in the preparation of protein vaccine and nucleic acid vaccine. Further studies are required to confirm its safety and efficacy as a diagnostic means.
作者 舒勇 孙丹宁
出处 《中华男科学杂志》 CAS CSCD 2004年第5期382-384,共3页 National Journal of Andrology
关键词 干细胞抗原 前列腺 stem cell antigen prostate cancer
  • 相关文献

参考文献25

  • 1Reiter RE, Gu Z, Watabe T, et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer[J]. Proc Natl Acad Sci USA, 1998, 95(4):1735-1740. 被引量:1
  • 2Bussemakers MJ, Changes in gene expression and targets for therapy[J]. Eur Urol, 1999, 35(5-6) :408-412. 被引量:1
  • 3Yang D, Holt GE, Velders MP, et al. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice[J]. Cancer Res, 2001, 61(15):5857-5860. 被引量:1
  • 4Nakamura K, Yasunaga Y, Ko D, et al. Cadmium-induced neoplastic transformation of human prostate epithelial cells[J]. Int J Oncol, 2002, 20(3):543-547. 被引量:1
  • 5Dubey P, Wu H, Reiter RE, et al. Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression[J].Cancer Res, 2001,61(8):3256-3261. 被引量:1
  • 6Christiansen J J, Rajasekaran SA, Moy P, et al. Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line[J]. Prostate, 2003, 55(1):9-19. 被引量:1
  • 7Gu Z, Thomas G, Yamashiro J, et al. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer[J]. Oncogene,2000, 19(10):1288-1296. 被引量:1
  • 8Tran CP, Lin C, Yamashiro J, et al. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells[J]. Mol Cancer Res, 2002, 1(2):113-121. 被引量:1
  • 9Dannull J, Diener PA, Prikler L, et al. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer[J]. Cancer Res, 2000, 60(19):5522-5528. 被引量:1
  • 10Reiter RE, Sato I, Thomas G, et al. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer[J]. Genes Chromosomes Cancer, 2000, 27(1):95-103. 被引量:1

同被引文献23

  • 1王振林,王笑芳.血清前列腺特异性抗原与碱性磷酸酶测定在判断前列腺癌骨转移中的价值[J].中华男科学杂志,2005,11(11):825-827. 被引量:4
  • 2Roudier MP, Vesselle H, True LD, et al. Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: The effect of bisphosphonate therapy on bone scintigraphy results, Clin Exp Metastasis, 2003, 20 ( 2 ) : 171-180. 被引量:1
  • 3Singer FR, Eyre DR. Using biochemical markers of bone turnover in clinical practice. Cleve Clin J Med, 2008, 75 (10): 739 -750. 被引量:1
  • 4Yi B, Williams PJ, Niewolna M, et al. Tumor-derived plateletderived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer.Cancer Res, 2002, 62(3): 917-923. 被引量:1
  • 5Drake MT, Clarke BL, Kholsa S. Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clin Proc, 2008, 83 (9) : 1032-1045. 被引量:1
  • 6Wada N, Fujisaki M, Ishii S, et al. Evaluation of bone metabolic markers in breast cancer with bone metastasis. Breast Cancer, 2001, 8(2) : 131-137. 被引量:1
  • 7Bubendorf L, Schopfer A, Wagner U, et al. Metastatic patterns of prostate cancer: An autopsy study of 1589 patients. Hum Pathol, 2000, 31(5): 578-583. 被引量:1
  • 8Chen N, Ye XC, Chu K, et al. A secreted isoform of ErbB3 promotes osteoneetin expression in bone and enhances the invasiveness of prostate cancer cells. Cancer Res, 2007, 67 (14) : 6544- 6548. 被引量:1
  • 9Bonfil RD, Chinni S, Fridman R, et al. Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis. Urol Oncol, 2007, 25(5) : 407-411. 被引量:1
  • 10Ye L, Kynaston HG, Jiang WG. Bone metastasis in prostate cancer: Molecular and cellular mechanisms (Review). Int J Mol Med, 2007, 20(1) : 103-111. 被引量:1

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部